Fundraising FoxLilly Asia Ventures — 2018 Investments
5 investments dated 2018 · listed companies and verified rows first · show all
Avedro is an ophthalmic company focused on corneal health, known for bio-activated cross-linking therapies such as the KXL system and riboflavin-based treatments used to address progressive keratoconus.
BiotechHealthtechMedical DevicesWaltham, US
David F. Muller(Executive Officer, Director)inBrian J. Roberts(Executive Officer)inRhonda J. Bracey(Executive Officer)inThomas W. Burns(Chairman & Chief Executive Officer)
BoardJason Hong(Director)Jeff Dykan(Director)in
Board seatHongbo Lu· per SEC Form D
Co-investorsAPERTURE Venture PartnersLAVSCP Vitalife PartnersThird Point VenturesWestern Technology InvestmentAbingworth+5 more
KSQ Therapeutics develops eTIL therapies—engineered tumor-infiltrating lymphocyte treatments for solid tumors—using its proprietary CRISPRomics platform to identify and target novel therapeutic candidates through genome-wide CRISPR/Cas9 functional genomic screens.
AI & Machine LearningBiotechMedical DevicesCambridge, US
Tim Wang(Cofounder)JOHN TRZUPEK, PH.D.(TREASURER, SECRETARY & CHIEF FINANCIAL OFFICER)DAVID P. MEEKER, M.D.(PRESIDENT AND CHIEF EXECUTIVE OFFICER)inFRANK STEGMEIER, PH.D.(CHIEF SCIENTIFIC OFFICER)Qasim Rizvi(Chief Executive Officer)inJAMES GILBERT(Director)
PartnerHongbo Lu· solo GP
Co-investorsAlpha Wave GlobalARCH Venture PartnersFlagship PioneeringLAVLG Technology VenturesBaillie Gifford+3 more
San Diego clinical-stage biopharma developing non-bile acid FXR agonists for liver and gastrointestinal diseases.
BiotechSan Diego, US
Ronald Evans(Director)Trisha Millican(Executive Officer)Ken Song(Executive Officer, Director)
BoardKristina Burow(Director)inRichard Heyman(Director)inAmir Nashat(Director)in
PartnerHongbo Lu· solo GP
Co-investorsage1EcoR1 CapitalLAVLifeSci Venture PartnersNew Enterprise Associates (NEA)Vivo Capital+8 more
Singlera is a biotech company specializing in in vitro diagnostic reagents and instruments.
BiotechDeep TechDigital HealthHealthtechMedical DevicesShanghai, CN
Zhang Jiangli(Co-founder, Chairman & CEO)inZhang Hun(Co-founder)
PartnerHongbo Lu· solo GP
Co-investorsLAVDetong CapitalGreen Pine Capital Partners
Tmunity Therapeutics was a University of Pennsylvania spinout developing engineered T-cell therapies, including CAR-T and TCR-based treatments, for cancers.
BiotechPhiladelphia, US
Anne Chew(Director and President)
BoardKevin Mahoney(Director)
PartnerHongbo Lu· solo GP
Co-investorsAndreessen HorowitzKhosla VenturesKleiner PerkinsLAVMilitia Hill VenturesGilead Sciences
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.